Creina Standish Stockley

Dr. Creina Standish Stockley

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2019
Verified
Book Chapter
Open access
PDF file
TBTamara Bucher
Tamara Bucher
KDKristine Deroover
Kristine Deroover
CSCreina Standish Stockley
Creina Standish Stockley
Moderate wine consumption may be associated with specific health benefits and a healthy lifestyle. However, increased amounts of ethanol are cytotoxic and associated with adverse health outcomes. Alcohol reduction in wine might be an avenue to reduce alcohol related harm without forcing consumers to compromise on lifestyle and benefit from positive aspects of moderate consumption. The aim of this review is to give an overview of viticultural and pre and post fermentation methods to produce low-alcohol wine, and to summarize the current evidence on the consumer acceptance and behaviour related to low-alcohol wine. Strategies for the labelling and marketing of wines with reduced alcohol content are discussed.

22 August 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
CSCreina Standish Stockley
Creina Standish Stockley
RERobert Curtis Ellison
Robert Curtis Ellison
MBMladen Boban
Mladen Boban
Moderate wine consumption has historically been associated with a J-shaped relationship between dose and total mortality, driven primarily by cardiovascular protection, enhanced endothelial function, improved glucose metabolism, and anti-inflammatory and antioxidant effects attributable to both ethanol and grape-derived phenolic constituents. Yet in recent years, international alcohol guidelines have shifted markedly towards the assertion that ‘no safe level’ of alcohol exists. This transition has occurred despite the continued consistency of mechanistic, clinical, and epidemiological evidence demonstrating hormetic (biphasic) responses to wine and its constituents and despite methodological controversies over the mathematical models used in several recent national guideline revisions. This narrative review synthesises mechanistic evidence on hormesis and wine-specific biological effects—including polyphenols, resveratrol, nitric oxide signalling, platelet modulation, and endothelial benefits—with epidemiological data on J-shaped associations with cardiovascular disease, diabetes, and total mortality. It further examines key methodological changes in recent guidelines, particularly the adoption of the ‘Sheffield model’ and the exclusion of or reduced emphasis on cardioprotective outcomes. The review argues that these methodological decisions, rather than new scientific evidence, largely explain the departure from earlier guideline thresholds that allowed moderate wine consumption. Understanding wine’s biological specificity, the differential health implications of drinking patterns and contexts, and the limitations of model-driven policy changes is essential to develop coherent, evidence-informed public health recommendations.

18 November 2020 in Food & Function
Verified
Journal Article
Closed access
PDF file
PRPatrizia Restani
Patrizia Restani
Chiara Di LorenzoChiara Di Lorenzo
Chiara Di Lorenzo
Ursula FraderaUrsula Fradera
Ursula Fradera
CSCreina Standish Stockley
Creina Standish Stockley
PTPierre-Louis Teissedre
Pierre-Louis Teissedre
RKRena Kosti
Rena Kosti
This narrative review investigates whether low/moderate consumption of wine/grape's derivatives can be part of T2D individuals daily diet.

8 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
CSCreina Standish Stockley
Creina Standish Stockley
MMMarjana Martinic
Marjana Martinic
The relationship between the consumption of wine and other alcoholic beverages and health remains one of the most debated topics in nutrition and public health. Although many national drinking guidelines draw on broadly similar epidemiological evidence, they often yield markedly different recommendations on alcohol consumption and risk. These differences are particularly evident in debates over moderate consumption, where conclusions about potential cardiovascular benefits, cancer risks, and overall health effects vary with how evidence is evaluated and translated into public health advice. This review examines the principal methodological frameworks used to develop drinking guidelines over the past two decades. Five broad approaches are identified: synthesis of observational evidence, quantitative disease-risk modelling, precautionary public health approaches, continuum-of-risk communication, and integrated absolute-risk frameworks. Using examples from the United States (U.S.), the United Kingdom (U.K.), the Netherlands, Canada and Australia, we examine the scientific assumptions, methodological choices and policy judgements that underpin each framework, and demonstrate how they influence both risk assessment and the resulting recommendations. Our analysis suggests that differences between national drinking guidelines stem not only from the interpretation of scientific evidence but also from fundamentally different conceptual approaches to assessing and communicating alcohol-related risk. Factors such as beverage type, drinking pattern, dietary context, lifestyle behaviours, and the selection of acceptable risk thresholds are incorporated to varying degrees across guideline methodologies, leading to divergent conclusions about moderate alcohol consumption. Drawing on the strengths of existing approaches, we propose an integrated framework for developing future drinking guidelines that separates scientific evidence from policy judgement, incorporates both lifetime and short-term risks, and communicates risk transparently within the broader context of diet and lifestyle. Such an approach provides a more coherent basis for improving health literacy and may assist policymakers and consumers in interpreting evidence on moderate alcohol consumption, including wine consumed as part of healthy dietary patterns.